Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys + Copegus duration in biochemical responders but virological non-responders (genotype 1 HCV)
2005-004531-22Phase 3Completed
- Sponsor
- Májbetegekért Alapítvány
- Start
- Dec 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of interferon alfa and ribavirin in hepatitis C virus infection (2 arms), sponsored by Májbetegekért Alapítvány. Primary endpoint: Sustained virological response. Started Dec 2005; status: completed.
02
Drugs
interferon alfaribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2005-004531-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004531-22.